Pfizer Ends Sangamo Alliance With Gene Therapy for Hemophilia on Cusp of FDA Filing
Posted:
Pfizer is walking away from partner Sangamo Therapeutics ahead of expected regulatory submissions for the hemophilia A gene therapy they co-developed. Cash-strapped Sangamo said it is now looking for a new partner for the program.
Read the full article in the latest MedCity News blog post here.
NHS clinicians will be supported to use groundbreaking AI tools that bulldoze bureaucracy and take notes to free up staff time and deliver better care to patients thanks to guidance published today.
Read more here.
A new technology partnership formally announced today, could help NHS, local government, and housing organisations collaborate to create an unprecedented understanding of the risks and needs of people in their care.
Read more here.
Attendees
Sponsors and Exhibitors
AI In Healthcare: A Virtual Course
Contact us